Zobrazeno 1 - 10
of 48
pro vyhledávání: '"M. N Starovoitova"'
Autor:
M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 53-60 (2023)
In systemic sclersis (SSc), different types of renal involvement occur. Their severity can range from asymptomatic deterioration of renal function to life-threatening damage, which is a complex therapeutic problem. Rituximab (RTM) has been used in th
Externí odkaz:
https://doaj.org/article/5c9f566b36bd4479822c02a33d3e7a38
Autor:
A. O. Efremova, N. V. Toroptsova, O. V. Dobrovolskaya, M. N. Starovoitova, O. V. Desinova, O. A. Nikitinskaya
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 592-598 (2021)
Aim of the research – to determine the frequency of osteoporosis (OP) and to identify risk factors for a decrease in bone mineral density (BMD) in postmenopausal women with systemic sclerosis (SSс).Subjects and methods. The study included 113 post
Externí odkaz:
https://doaj.org/article/08e309d945db4fc9ae2a5e8f0aa0e99d
Publikováno v:
Современная ревматология, Vol 15, Iss 2, Pp 64-68 (2021)
The group of scleroderma diseases includes a number of clinical entities, the main symptom of which is skin tightening. Scleroderma is a prominent example of these diseases, characterized by excessive synthesis and deposition of collagen in organs an
Externí odkaz:
https://doaj.org/article/45db618c195f414cacccd46d0b2c461e
Autor:
O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoitova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 66-72 (2021)
Autologous hematopoietic stem cell transplantation (auto-HSCT) is presently the only disease-modifying strategy for the treatment of systemic sclerosis (SSs) that has Level A evidence, the effectiveness of which has been proven in three controlled cl
Externí odkaz:
https://doaj.org/article/6970a796db08439590e7c365a886818c
Autor:
O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, R. U. Shayakhmetova, O. V. Desinova, M. N. Starovoitova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 91-97 (2020)
Diffuse cutaneous systemic sclerosis (SSc) characterized by an acute, rapidly progressive course and severe damage to the internal organs has an unfavorable prognosis, while the treatment of this often fatal type of the disease has not been sufficien
Externí odkaz:
https://doaj.org/article/b14a6e61fde04e20af5a4f49e5b3fe21
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 49-56 (2020)
In anti-U1-ribonucleoprotein (anti-U1-RNP) antibody positive patients with systemic scleroderma (SSD), the clinical picture and course of the disease have specific features: there is a preponderance of its limited form; inflammatory damage to the joi
Externí odkaz:
https://doaj.org/article/d8c78c75aa6542c1b2a396e80c6268f8
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 1, Pp 48-54 (2020)
Various clinical and immunological phenotypes of systemic sclerosis (SS) differ in the frequency and severity of manifestations of the disease, the progression of damage to internal organs, and prognosis. The detection rate of anti-U1-ribonucleoprote
Externí odkaz:
https://doaj.org/article/56c9458eb80046748424290ef5553d6f
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 5, Pp 539-544 (2019)
Among the patients fulfilling the criteria for systemic sclerosis (SS), there is a subgroup without SS-specific antinuclear antibodies, but positive for anti-ribonucleoprotein (anti-U1 RNP) antibodies. The clinical significance of this type of antinu
Externí odkaz:
https://doaj.org/article/6359d0bff2344c629f0a39c3be43d122
Autor:
L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 3, Pp 265-273 (2019)
The choice of drugs for the treatment of interstitial lung disease (ILD) associated with systemic sclerosis (SS) is currently very limited. Data from a number of studies show that rituximab (RTM) can improve lung function and reduce the severity of s
Externí odkaz:
https://doaj.org/article/fb2372c816e44d50a10380459139c10a
Autor:
M. N. Starovoitova, O. V. Desinova
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 6, Pp 777-781 (2019)
As of now, there are several pharmacological directions in the treatment and prevention of Raynaud’s syndrome and digital ulcers, including various vasoactive drugs (calcium channel blockers, intravenous prostanoids, endothelin receptor antagonists
Externí odkaz:
https://doaj.org/article/dd912c711e4349fb9993340db3da12d9